Full Merger Agreement Filed: Accelerant Holdings and Thoma Bravo Detail $20.25/Share Cash Deal with 82% Voting Support
ARX has more than doubled off its 52-week low of $9.18 on elevated volume (22× avg).
Summary
The full merger agreement with Thoma Bravo has been filed, detailing the $20.25 per share cash deal, 82% voting support, go-shop period, and termination fees.
Key Events · M&A and Partnerships · ARX
-
Merger Agreement Filed
A definitive merger agreement with Thoma Bravo affiliates was entered into on August 13, 2026, for $20.25 per share in cash, a 49% premium to the prior closing price.
-
82% Voting Support Secured
ACP Insurance Management, LLC and ACP Accelerant Holdings, L.P., holding approximately 82% of outstanding voting rights, signed a Voting and Support Agreement to vote in favor of the merger.
-
Go-Shop Period Until Sept 22
A go-shop period until September 22, 2026, allows the company to solicit alternative acquisition proposals from excluded parties.
-
Ticking Fee for Delays
If closing occurs after the Ticking Amount Start Date, shareholders receive an additional $0.00333 per share per day until specified insurance regulatory approvals are obtained.
Analysis · ARX · Finance
The complete merger agreement between Accelerant Holdings and Thoma Bravo has been filed, laying out the full terms of the $20.25 per share cash acquisition. Notably, shareholders representing approximately 82% of voting rights have already committed to support the deal, making approval highly likely. The agreement includes a go-shop period until September 22, 2026, allowing the company to solicit alternative proposals, and a ticking fee of $0.00333 per share per day if closing is delayed. Termination fees are substantial: $136.5 million payable by the company in most cases, and $295.8 million payable by Thoma Bravo if it fails to close. Financing risk is reduced by an equity commitment letter from Thoma Bravo Discover Fund V, L.P., and a guarantee from the sponsor. The merger is expected to close in 2027, subject to regulatory approvals and shareholder vote.
At the time of this filing, ARX was trading at $19.49 on NYSE in the Finance sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $9.18 to $30.48. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.